US Patent Issued to Newave Pharmaceutical on Sept. 9 for "Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases" (California Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,190, issued on Sept. 9, was assigned to Newave Pharmaceutical Inc. (Pleasanton, Calif.).

"Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases" was invented by Yi Chen (Pleasanton, Calif.) and Yan Lou (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure includes compounds of Formula (A):wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, and R12, j, k, m, n, Y, W, W1, W2, W3, V, L, Z1, Q1, Q2, Q3, and Q4, are defined herein. Also disclosed is a method for treating a neoplastic disease, an autoimmune disease, or a neorodegenerative disease with these compounds."

The patent was ...